fda ruling semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA approves obesity drug that

3 Steps to Protect Patients from Fake Weight Loss Medications Advise patients to only buy medication with a prescription and from a licensed pharmacist

A., Sakatani, T., Sugamura, K., Makino, M., Ito, H., Savaraj, N., Kaibara, N., and Kuo, M

For shoulder tendons with poor vascular supply, this is potentially transformative

Metabolism 63:919 Del Olmo-Garcia MI, Merino-Torres JF (2018) GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes

Bacteroides spp

No potential mutagenicity of tesamorelin acetate was revealed in a battery of tests including induction of gene mutations in bacteria (the Ames test), gene mutations in mammalian cells grown in vitro (hamster CHOK1 cells), and chromosomal damage in intact animals (bone marrow cells in mice)